471 related articles for article (PubMed ID: 30944972)
21. Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?
Werner JM; Lang C; Scherer MN; Farkas SA; Geissler EK; Schlitt HJ; Hornung M
Transpl Immunol; 2011 Jul; 25(1):27-33. PubMed ID: 21635950
[TBL] [Abstract][Full Text] [Related]
22. Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus.
Tang S; Wang Y; Ma X; Xiang X; Zhou X; Li Y; Jia Y; Hu F; Li Y
Clin Rheumatol; 2023 May; 42(5):1435-1442. PubMed ID: 36629999
[TBL] [Abstract][Full Text] [Related]
23. CD8
Kumari S; Shivam P; Hansa J; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Hum Immunol; 2018 Aug; 79(8):616-620. PubMed ID: 29842895
[TBL] [Abstract][Full Text] [Related]
24. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
25. Impaired natural killer cell subset phenotypes in human obesity.
Bähr I; Jahn J; Zipprich A; Pahlow I; Spielmann J; Kielstein H
Immunol Res; 2018 Apr; 66(2):234-244. PubMed ID: 29560551
[TBL] [Abstract][Full Text] [Related]
26. Increased ILT2
Chen N; Dai Y; Li H; Long X; Ke J; Zhang J; Sun H; Gao F; Lin H; Yan Q
Clin Rheumatol; 2023 Nov; 42(11):3113-3121. PubMed ID: 37695380
[TBL] [Abstract][Full Text] [Related]
27. The Increased Ratio of Blood CD56
Ming B; Wu T; Cai S; Hu P; Tang J; Zheng F; Ye C; Dong L
J Immunol Res; 2020; 2020():7523914. PubMed ID: 32695834
[TBL] [Abstract][Full Text] [Related]
28. Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity.
Cho YN; Kee SJ; Lee SJ; Seo SR; Kim TJ; Lee SS; Kim MS; Lee WW; Yoo DH; Kim N; Park YW
Rheumatology (Oxford); 2011 Jun; 50(6):1054-63. PubMed ID: 21278064
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
[TBL] [Abstract][Full Text] [Related]
31. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.
Bonacini M; Soriano A; Zerbini A; Calò E; Cimino L; Muratore F; Fontana L; Braglia L; Parmeggiani M; Salvarani C; Croci S
Front Immunol; 2018; 9():2157. PubMed ID: 30319620
[TBL] [Abstract][Full Text] [Related]
32. The aberrant expression of stimulatory and inhibitory killer immunoglobulin-like receptors in NK- and NKT-cells contributes to lupus.
Bai Y; Zhang Y; Yang Q; Hou Y; Hu N; Wang D; Sun H
Clin Lab; 2014; 60(5):717-27. PubMed ID: 24839813
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.
Cruz-González DJ; Gómez-Martin D; Layseca-Espinosa E; Baranda L; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R; Monsiváis-Urenda AE
Clin Exp Immunol; 2018 Mar; 191(3):288-300. PubMed ID: 29058308
[TBL] [Abstract][Full Text] [Related]
34. Decline in peripheral blood NKG2D+CD3+CD56+ NKT cells in metastatic colorectal cancer patients.
Gharagozloo M; Rezaei A; Kalantari H; Bahador A; Hassannejad N; Maracy M; Nouri N; Sedghi M; Ghazanfari H; Bayat B
Bratisl Lek Listy; 2018; 119(1):6-11. PubMed ID: 29405723
[TBL] [Abstract][Full Text] [Related]
35. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.
Lima M; Almeida J; Montero AG; Teixeira Mdos A; Queirós ML; Santos AH; Balanzategui A; Estevinho A; Algueró Mdel C; Barcena P; Fonseca S; Amorim ML; Cabeda JM; Pinho L; Gonzalez M; San Miguel J; Justiça B; Orfão A
Am J Pathol; 2004 Oct; 165(4):1117-27. PubMed ID: 15466379
[TBL] [Abstract][Full Text] [Related]
36. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings.
Waldron J; Raymond W; Ostli-Eilertsen G; Nossent J
Lupus; 2018 May; 27(6):963-970. PubMed ID: 29385899
[TBL] [Abstract][Full Text] [Related]
38. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
Pierson BA; Miller JS
Blood; 1996 Sep; 88(6):2279-87. PubMed ID: 8822949
[TBL] [Abstract][Full Text] [Related]
39. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin.
Wajchman HJ; Pierce CW; Varma VA; Issa MM; Petros J; Dombrowski KE
Cancer Res; 2004 Feb; 64(3):1171-80. PubMed ID: 14871854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]